Baupost Group SKIN trades
Seth Klarman
Seth Klarman VESPER HEALTHCARE ACQUISIT-A stake
total: 272
Trades details
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2020 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2021 Q1
According to 2026 Q2 report, Seth Klarman doesn't hold any VESPER HEALTHCARE ACQUISIT-A (SKIN) shares. To date, the estimated cost basis is nearly $226.2 for "buy" trades and estimated average "sell" price is $226.2. Baupost Group first purchased SKIN in 2020 Q4, initially acquiring 198,000 shares. Since the initial investment in VESPER HEALTHCARE ACQUISIT-A (SKIN), Baupost Group has made 1 more transaction.
When did Seth Klarman sell VESPER HEALTHCARE ACQUISIT-A (SKIN)?
Seth Klarman sold off the entire VESPER HEALTHCARE ACQUISIT-A (SKIN) position in 2021 Q1.
When did Seth Klarman buy VESPER HEALTHCARE ACQUISIT-A (SKIN)?
Seth Klarman first invested in VESPER HEALTHCARE ACQUISIT-A (SKIN) in 2020 Q4 at the reported quarter-end price of $226.20 per share.
What's the cost basis of Baupost Group's SKIN stake?
The estimated cost basis for VESPER HEALTHCARE ACQUISIT-A (SKIN) stake is around $226.20 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $226.20
- Weighted AVG sell price:
- $226.20
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.